ArticleBMC cardiovascular disorders2025
Balloon dilation of the para-device space to alleviate severe flow restriction in an oversized pulmonary flow restrictor: a case report.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManually modified microvascular plugs (MVPs) to pulmonary flow restrictors (PFRs) are innovative devices for managing pulmonary overcirculation percutaneously, though achieving optimal restriction while maintaining device stability can be challenging. CASE PRESENTATION: We describe a full-term newborn with a double outlet right ventricle and a large malaligned subaortic ventricular septal defect, complicated by pulmonary overcirculation. At 24 days of life (2.4 kg, 50 cm), bilateral MVP-based PFRs were implanted, with an MVP-7Q placed in the right pulmonary artery (4.1 mm diameter) and an MVP-5Q in the left (3.8 mm diameter), after fenestrating the MVPs by removing one triangle with a surgical scalpel. Immediate severe flow restriction to the right lung was managed with dilation of the para-right PFR space using 2 mm and then 3 mm semi-compliant coronary balloons, increasing oxygen saturation from 60 to 87%. By the end of the procedure, the Qp: Qs ratio decreased from 2.3:1.0 to 1.1:1.0. At 12 weeks, the patient weighed 4.8 kg, with oxygen saturation at 92% and Doppler gradients of 70 mmHg on the left and 45 mmHg on the right. Nine months post-intervention, the patient underwent biventricular repair and PFR removal at 7.9 kg. A fibrotic endothelial reaction with wall thinning on the right required autologous patch repair. A two-week follow-up ultrasound showed no stenosis.
conclusionsPara-device space dilation with semi-compliant coronary balloons effectively relieves severe flow restriction in oversized PFRs, restoring flow while preserving device integrity. However, long-standing oversized PFRs cause intimal damage, necessitating patch repair, despite excellent surgical outcomes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.